Clinical Observation on Shugan Weian Granules(疏肝胃安颗粒) Combined with Esomeprazole and Mosapride in the Treatment of 56 Cases of Gastroesophageal Reflux Disease
ZHOU Yingwu, ZHANG Yulu. Clinical Observation on Shugan Weian Granules(疏肝胃安颗粒) Combined with Esomeprazole and Mosapride in the Treatment of 56 Cases of Gastroesophageal Reflux Disease[J]. Journal of Traditional Chinese Medicine2019, 60(13): 1118-1122.
ZHOU Yingwu, ZHANG Yulu. Clinical Observation on Shugan Weian Granules(疏肝胃安颗粒) Combined with Esomeprazole and Mosapride in the Treatment of 56 Cases of Gastroesophageal Reflux Disease[J]. Journal of Traditional Chinese Medicine2019, 60(13): 1118-1122.DOI: 10.13288/j.11-2166/r.2019.13.009.
Objective To evaluate the clinical efficacy of Shugan Weian Granules(疏肝胃安颗粒) combined with esomeprazole and mosapride in the treatment of gastroesophageal reflux disease(GERD).Methods Totally120 patients with GERD were randomly divided into a control group(60 cases) and a treatment group(60 cases).The control group was given esomeprazole magnesium enteric-coated tablets 20 mg each time
twice a day
and mosapride 5 mg each time
3 times a day.On the basis of the control group
the treatment group was given Shugan Weian Granules additionally
one dose per day.The treatment course of both group was 8 successive weeks.Before and after treatment
reflux disease questionnaire scale(RDQ)
SF-36 quality of life scale
and 24-hour esophageal pH monitoring were observed respectively.After treatment
the curative effect of both groups was analyzed according to the changes of the electronic gastroscope grading score before and after treatment.Results After treatment
the symptom scores of acid reflux
reflux
heartburn and non-cardiogenic chest pain and the total score of RDQ were significantly decreased in both groups(P<0.01)
while total score of RDQ and scores of all symptoms in the treatment group showed more significant decrease than those in the control group(P<0.05 or P<0.01).In SF-36 scale
all scores in the treatment group and scores except the emotional function and mental health in the control group were significantly increased than those before treatment(P<0.05).And the treatment group showed better improvement in physiological function
body pain
general health
emotional function
and mental health compared with the control group(P<0.05 or P<0.01).The number of reflux lasting ≥5 min
the longest reflux duration
time percentage of pH<4
De Meester scoring were significantly reduced in both groups(P<0.05 or P<0.01).Additionally
the longest reflux duration and DeMeester scoring showed more significant decrease in the treatment group compared with the control group(P<0.05).There was no significant difference in the total effective rate of the gastroscopic examination between the 2 groups(P > 0.05)
although the rate of the control group was 77.19%
and the treatment group85.71%.Conclusion Shugan Weian Granules combined with esomeprazole and mosapride could significantly improve the clinical symptoms and life quality of GRD patients.The clinical effect of combined treatment is superior to using western medicine treatment alone.